VTGN - Vistagen Therapeutics appoints CFO
2023-08-22 08:48:52 ET
More on VistaGen Therapeutics
- Vistagen Therapeutics, Inc. ( VTGN ) Q1 2024 Earnings Call Transcript
- Vistagen up 905% on phase 3 social anxiety drug results
- Vistagen posts real world data to highlight hot flashes therapy
- Seeking Alpha’s Quant Rating on VistaGen Therapeutics
- Earnings data for VistaGen Therapeutics
For further details see:
Vistagen Therapeutics appoints CFO